PNT

POINT Biopharma Global Inc. Common Stock

Delisted

PNT was delisted on the 26th of December, 2023.

115 hedge funds and large institutions have $455M invested in POINT Biopharma Global Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 34 increasing their positions, 37 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more funds holding

Funds holding:

2% more capital invested

Capital invested by funds: $446M → $455M (+$9.47M)

8% less repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 37

Holders
115
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$66K
Puts
$1K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
51
$621K
52
$506K
53
$496K
54
$485K
55
$465K
56
$452K
57
$435K
58
$434K
59
$428K
60
$406K
61
$378K
62
$372K
63
$337K
64
$329K
65
$305K
66
$287K
67
$268K
68
$259K
69
$248K
70
$242K
71
$238K
72
$238K
73
$233K
74
$231K
75
$227K